MMMehmet Maden

Mehmet Maden

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mehmet Maden has a total of 83 co-authors. Here are the top co-authors by number of shared publications:

  • Erdem Gülersoy

    Harran Universitesi

    6 shared publications
  • B. Tras

    Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Selcuk University, 42003, Konya, Turkey

    2 shared publications
  • M. Arican

    Department of Surgery, Faculty of Veterinary Medicine, Selcuk University, 42003, Konya, Turkey

    2 shared publications
  • M. Ider

    Department of Internal Medicine, Faculty of Veterinary Medicine, Selcuk University, 42003, Konya, Turkey

    2 shared publications
  • R. Yildiz

    Department of Internal Medicine, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, 15030, Burdur, Turkey

    2 shared publications
  • R. Çöl

    Department of Physiology, Faculty of Veterinary Medicine, Selcuk University, 42003, Konya, Turkey

    2 shared publications

Latest Publications

  • Open Access

    Hepatocutaneous syndrome in a dog with concurrent Ehrlichiosis: Case report

    by Mehmet Maden, Mahir Kaya, Kezban Topaç, Orhun Göğebakan, Nuri Kaan Dönmez, Erdem Gülersoy

    This report describes the diagnosis of hepatocutaneous syndrome in a dog concurrently affected by Ehrlichiosis. A 13-year-old Golden Retriever presented with lethargy, fever, lymphadenopathy, and dermatological lesions on the paws, perianal region, and testes, characterized by hyperkeratosis, erosion, ulceration, crusting, and exudation. Clinicopathological evaluation revealed regenerative anemia, lymphopenia, monocytopenia, basophilia, thrombocytopenia, and increased serum activities of alkaline phosphatase, alanine transaminase, and gamma-glutamyl transferase. After ruling out other vector-borne diseases (e.g., Leishmaniasis, Anaplasmosis, Babesiosis), Ehrlichiosis was diagnosed. Abdominal ultrasonography revealed a honeycomb-like hepatic echotexture, and differential diagnoses for hepatocutaneous syndrome included pemphigus foliaceus/vulgaris, systemic lupus erythematosus, drug eruptions, and zinc-responsive dermatosis. Ultimately, the clinical, laboratory, and ultrasonographic findings supported concurrent diagnoses of hepatocutaneous syndrome and Ehrlichiosis. The dog died, most likely due to severe hepatic dysfunction and associated coagulopathy; disseminated intravascular coagulation was suspected based on the clinical course, although it could not be confirmed due to the absence of coagulation testing, despite receiving combination therapy that included vitamin–amino acid infusion, ursodeoxycholic acid, antioxidant nutraceuticals (S-adenosylmethionine, Silybum marianum, phospholipids, zinc), omega-3 fatty acids, and benzoyl peroxide shampoo for hepatocutaneous syndrome, in addition to doxycycline and prednisolone for ehrlichiosis. This case report highlights the diagnostic complexity of hepatocutaneous syndrome, particularly when concurrent with infectious diseases such as Ehrlichiosis. It demonstrates how overlapping clinical signs can complicate diagnosis and delay appropriate treatment. To the authors’ knowledge, this is the first documented case of hepatocutaneous syndrome in a dog concurrently diagnosed with Ehrlichiosis. By presenting this case, we aim to raise awareness among veterinary clinicians of the importance of a thorough diagnostic workup in dogs exhibiting compatible dermatologic and systemic signs, even in regions endemic for tick- borne diseases.

  • Open Access

    The clinical efficacy of cGMP-specific sildenafil on mitochondrial biogenesis induction and renal damage in cats with acute on chronic kidney disease

    by Mehmet Maden, Merve Ider, Mehmet Erman Or, Banu Dokuzeylül, Erdem Gülersoy, Merve Cansu Kılıçkaya, Bengü Bilgiç, Murat Kaan Durgut, Semih İzMirli, Suleyman Serhat Iyigün, et al.

    Mitochondrial biogenesis (MB) induction has recently emerged as potential therapeutic approaches in kidney pathology and the mitochondria-targeted therapies should be investigated to improve treatment of animals with kidney diseases. This study aimed to investigate the effects of MB induction with sildenafil citrate on the cGMP/NO pathway, glomerular filtration, and reduction of kidney damage and fibrosis (TGF-β/SMAD pathway) in cats with acute on chronic kidney disease (ACKD). Thirty-three cats were divided into the non-azotemic (healthy) group (n:8) and the ACKD group (n:25), comprising different breeds, sexes, and ages. Sildenafil citrate was administered to the non-azotemic and ACKD groups (2.5 mg/kg, PO, q12 hours) for 30 days. Serum and urine NO, MDA, NGAL, KIM-1, TGF-β1, IL-18, FGF 23, PGC-1α and cGMP concentrations were measured. Serum cGMP concentrations increased (P < 0.05) in the non-azotemic group during the 2nd (median 475.99 pmol/mL) and 3rd (median 405.01 pmol/mL) weeks of the study, whereas serum cGMP concentrations decreased in the ACKD group during the 4th(median 188.52 pmol/mL) week compared to the non-azotemic group (P < 0.05). No difference was observed in serum biomarker concentrations except NO, which increased in the 4th week (P < 0.05). The urinary concentrations of NO, MDA, PGC-1α, TGF-β1, NGAL, KIM-1, IL-18, and FGF 23 in the ACKD group were found to be higher compared to those in the non-azotemic group from the 1st to the 4th week (P < 0.05). In the ACKD group, the urine PGC-1α concentration in the 2nd (median 6.10 ng/mL) week was lower compared to that in the 0 and 1st (median 7.65 and 7.21 ng/mL, respectively) week, and the NO concentration in the 3rd (median 28.94 µmol/mL) week was lower than that in the 0th (median 37.43 µmol/mL) week (P < 0.05). While sildenafil citrate has been determined to induce a low level of MB and to have a beneficial effect on glomerular filtration, it is observed to be ineffective in mitigating renal damage and fibrosis via the TGF-β/SMAD pathway in cats with ACKD.


  • Open Access

    Serum/Faecal S100A12, CRP and lactoferrin can be used to distinguish ınfectious and non‐ınfectious canine diarrhoea

    by Mehmet Maden, Erdem Gülersoy

    Objectives: This study aimed to evaluate the diagnostic efficacies of selected inflammatory and intestinal biomarkers in cases of infectious and non‐infectious diarrhoea in dogs.Methods: A total of 60 dogs, 12 healthy (Control Group) and 48 with diarrhoea were used. Viral, Bacterial, Parasitic (infectious) and Nutritional diarrhoea (non‐infectious) subgroups (n: 12) were formed according to the aetiology, on the basis of clinical and laboratory examinations. Selected inflammatory and intestinal biomarkers (Calgranulin, S100A12; Lactoferrin, LCTF; C‐reactive protein, CRP) were measured both in serum and faecal samples.Results: Compared to the Control and Nutritional Diarrhoea groups, the infectious diarrhoea groups had higher serum S100A12, LCTF, CRP, blood urea nitrogen, creatinine (CR), alanine transaminase and alkaline phosphatase, and lower glucose (GLU), sodium (Na) and potassium (K) concentrations (p < 0.05); Viral and Parasitic Diarrhoea groups had lower serum albumin (ALB) and total protein (TP) concentrations (p < 0.05). Faecal S100A12, LCTF and CRP concentrations were higher in infectious diarrhoea groups compared to the Control and Nutritional Diarrhoea groups (p < 0.05). Faecal LCTF and CRP concentrations were higher in the Bacterial Diarrhoea group than in the Viral and Parasitic Diarrhoea groups (p < 0.05).Clinical significance: It was determined that serum (area under curve, AUC: 0.842 and 0.956) and faecal (AUC: 0.975 and 0.786) S100A12 and CRP concentrations in viral diarrhoea; serum (AUC: 0.956) and faecal (AUC: 0.992) LCTF concentrations in bacterial diarrhoea have diagnostic values in the diagnosis of the presence of intestinal inflammation and damage and can be used in the differential diagnosis of infectious and non‐infectious diarrhoea.


  • Diagnostic effectiveness of stress biomarkers in cats with feline interstitial and bacterial cystitis

    by Erdem Gülersoy, Mehmet Maden, Tuğba Melike Parlak, Zafer Sayin

    Background: Although bacterial cystitis (BC) and feline interstitial cystitis (FIC) are categorized under feline lower urinary tract disease (FLUTD) due to their similar clinical manifestations, stress is an important factor for FIC. Therefore, the investigation of stress biomarkers might be important in the differentiation and elucidation of these conditions.Objectives: We aimed to evaluate the diagnostic effectiveness of serum and urine cortisol, serotonin, and dopamine concentrations and their relationship with stress in cats with FIC and BC.Methods: Twelve healthy cats (Control group) and 24 cats with FLUTD were used. The cats with FLUTD were divided into FIC and BC groups.Results: Multimodal environmental modification (MEMO) scores were found to be higher in the FIC group than in the BC and Control groups (P < .001). Urine serotonin concentrations were higher in cats with FIC and BC compared with those in the Control group. Based on ROC analyses, the sensitivity, specificity, and accuracy of urine serotonin and dopamine were found to be statistically significant in being able to differentially diagnose cats in the FIC group vs the Control group. The sensitivity, specificity, and accuracy of serum dopamine were also found to be statistically significant for the differential diagnosis of FIC and BC.Conclusions: High urine serotonin concentrations were found in cats with FLUTD compared with healthy controls and interpreted as the presence of stress not only in cats with FIC but also in cats with BC. Also, based on the ROC‐based diagnostic performance evaluation of these stress biomarkers, urine serotonin, and dopamine concentrations can be used to diagnose FIC, and serum dopamine concentrations can be used to differentiate FIC and BC in cats.


  • Comparative evaluation of selected serum and urine biomarkers in cats with interstitial and bacterial cystitis

    by Erdem Gülersoy, Mehmet Maden, Tuğba Melike Parlak, Zafer Sayin

    Background Although feline urine is increasingly submitted for bacterial culture and susceptibility testing in veterinary practice, bacterial cystitis (BC) is relatively uncommon compared with feline interstitial cystitis (FIC), which shares similar clinical manifestations. Therefore, an investigation of certain urothelial (glycosaminoglycan [GAG], tissue inhibition metalloproteinase-2 [TIMP-2]), cytokine (interleukin 12 [IL-12]), and neurotrophic factor (nerve growth factor [NGF]) markers may aid diagnosis. Objectives We aimed to evaluate the diagnostic effectiveness of selected serum/urine biomarkers in the diagnosis of cats with FIC and BC. Methods Twelve healthy cats (Control group) and 24 cats with feline lower urinary tract disease (FLUTD) were used, and the cats with FLUTD were divided into FIC and BC groups. Results When comparing the three groups, serum GAG, IL-12, NGF, and TIMP-2 concentrations were highest in the FIC group; urine GAG, IL-12, NGF, and TIMP-2 concentrations were higher in the FIC and BC groups than those in the Control group. Serum NGF concentrations were higher in the FIC group than in all other groups. Also, serum GAG, IL-12, NGF, and TIMP-2 concentrations were found to be effective in the differential diagnosis of FIC vs BC. Conclusions We showed that serum NGF is a candidate biomarker that could be used in the diagnosis and differentiation of FIC. Urine GAG, IL-12, NGF, and TIMP-2 concentrations might be helpful in determining urinary bladder inflammation and/or damage in cats with FIC and BC. ROC analyses revealed that serum and urine biomarkers were effective for diagnosing FIC and that serum biomarkers rather than urine biomarkers were effective for the differential diagnosis of FIC and feline BC.


  • Open Access

    Buzağı Kayıplarının Önlenmesinde Buzağı Sağlığı ve Yetiştiriciliği

    by İbRar Ahmed, Fahrettin Alkan, Mustafa Arıcan, Oya Bulut, Onur Ceylan, Behiç Coşkun, Mustafa Çam, Muhammed Furkan Çiftçi, Sakine Ülküm Çizmeci, Erdem Danyer, et al.

    Türkiye’de son yıllarda büyükbaş hayvancılık sektöründe önemli değişimler yaşanmıştır. Bu süreçte birim hayvan başına düşen verim düzeyleri artmış olmakla birlikte; nüfus artışıyla birlikte oluşan damızlık ve kasaplık hayvan talebi iç piyasadan yeterince karşılanamamıştır. Ülkemizde artan hayvansal ürün ihtiyacının karşılanabilmesi yanında ithalatın azaltılabilmesi ve sürdürülebilir bir hayvancılık için hayvansal üretimdeki kayıpların en aza indirilmesi gerekmektedir. Bu bağlamda sığırcılık işletmelerinde en önemliüretim zararlarından birisi “buzağı kayıpları” olarak karşımıza çıkmaktadır. İneklerde Gebeliğin Elde Edilmesi ve Döl Verimi ile İlgili Kayıplar Hüseyin ERDEM İneklerde Gebelik Muayene Zamanlarının Planlanması Hüseyin ERDEM Fatma SATILMIŞ Kuru Dönemde Bakım ve Beslemenin Buzağı Sağlığı Üzerine Etkileri Behiç COŞKUN Mikotoksinlerin Buzağı Kayıplarına Etkisi Halis OĞUZ İneklerin Gebeliğinde Önemli Bir Sorun: Yavru Atıkları (Abortus) Fatma SATILMIŞ Furkan ÇİFTÇİ Ö. Faruk YEŞİLKAYA Hüseyin ERDEM Doğuma Yardımda Buzağı Kayıplar D. Ali DİNÇ S. Ülküm ÇİZMECİ Yeni Doğan Buzağılarda Kolostrum Yönetiminin Önemi Mahmut OK Prematüre (Günsüz) Doğan Buzağıların Bakımı Mahmut OK Sütten Kesim Döneminde Buzağıların Beslenmesi ve Buzağı Kayıplarının Önlenmesi Nurettin GÜLŞEN Buzağıların Süt Emme Dönemindeki Beslenmesi Fatma İNAL İbrar AHMED Buzağıları Hastalıklardan Koruma Yöntemleri Mahmut OK Buzağılarda Bakteriyel Hastalıklar Hüseyin HADİMLİ Buzağı Kayıplarına Neden Olan Viral Hastalıklar Oya BULUT Buzağı Kayıplarında Şap Hastalığının Rolü Murat ŞEVİK Mehmet Kürşat IŞIK Yeni Doğan Buzağılarda İshale Neden Olan Başlıca Paraziter Hastalık: Cryptosporidiosis Ferda SEVİNÇ Onur CEYLAN Buzağılarda Myiasis Uğur USLU Buzağılarda Coccidiosis Onur CEYLAN Ferda SEVİNÇ Buzağılarda Görülen Önemli Ektoparazitler Uğur USLU Buzağılarda Doğum Sonrası Dönemde Görülen Eklem Hastalıkları, Tedavi Seçenekleri ve Korunma Yolları Mustafa ARICAN Nuriza ZAMİRBEKOVA Buzağılarda Doğum Sırasında ve Sonradan Olan Kırık Olgularında Tedavi Seçenekleri Mustafa ARICAN Fehmiye GÜMÜŞ Birol ÖZDİL Yeni Doğan Buzağılarda Göbek Bölgesi Problemleri Fahrettin ALKAN Kurtuluş PARLAK Mustafa KUL Yeni Doğan Buzağılarda Acil Müdahaleler Mehmet MADEN Süt İnekleri ve Buzağılar İçin Aşılama Programları Hüseyin HADİMLİ Sığırlarda Akılcı İlaç Kullanımı Bünyamin TRAŞ Kamil ÜNEY Buzağı Barındırma Sistemleri Mustafa ÇAM Şeref İNAL Sığır İşletmelerinde Biyogüvenlik Erdem DANYER Sabri HACIOĞLU Cevdet YARALI Buzağı Kayıplarında İşletme Hatalarının Rolü Emine ÇİFTCİ Buzağı Yetiştirmede Refah Uygulamaları Kürşat IŞIK Buzağı Kayıpları ve Buzağı Hastalıklarının Ekonomik Değerlendirmesi Aytekin GÜNLÜ Sütçü Sığır İşletmelerinde Buzağı Kayıplarının Analizi: Nedenleri, Risk Faktörleri ve Hedefleri Mehmet MADEN Tarım ve Orman Bakanlığı Veteriner Kontrol Enstitüleri Erdem DANYER Sabri HACIOĞLU Cevdet YARALI Buzağı Yetiştirmede Kontrol ve Değerlendirme Listesi Şeref İNAL Mustafa ÇAM


  • Open Access

    An Overview to Complications of Chronic Kidney Disease in Dogs and Cats: Traditional Review

    by Mehmet Maden, Merve Cansu Kiliçkaya, Süleyman Serhat İyi̇gün

    Kronik böbrek hastalığı (KBH); böbreklerde önemli nefron kayıpları ile seyreden, geri dönüşümsüz (irreversibl) ve tipik olarak ilerleyici (progressive), yapısal ve/veya işlevsel bozukluk olarak tanımlanmaktadır. Başta orta ve ileri yaşlı kedi ve köpekler olmak üzere, her yaştaki evcil hayvanlarda görülen böbrek hastalıklarının en yaygın türüdür. KBH insidansı, köpek ve kedilerde sırasıyla %0,5-1,5 ve %1-3 arasında görülmektedir. Geriatrik kedilerde KBH prevalansının, geriatrik köpeklerden daha yüksek olduğu ve %35-81 gibi yüksek oranlarda seyrettiği bildirilmektedir. Tubulointerstisyel yangı ve fibrozis ile karakterize olan KBH; genetik, çevresel ve bireysel faktörlerin etkin olduğu karmaşık ve ilerleyici bir hastalık tablosu ile seyreder. Böbrek hasarına cevap olarak; hemodinamik adaptasyonlar, sistemik hipertansiyon, renin-anjiyotensin aldosteron sisteminin aktivasyonu, proteinüri, hiperfosfatemi, hipoksi ve oksidatif stres gelişir. Başlangıç nedeni ne olursa olsun, yangı ve fibrozise ilerleyen, yavaş seyirli böbrek hasarı oluşur. Hastalığın ilerlemesi ile ilişkili faktörlerin anlaşılması, hastalığın ilerlemesini yavaşlatabilen terapötik müdahale potansiyeli sağlar. Bu çerçevede böbrek fonksiyonu, homeostatik adaptasyonlar ve böbrek hasarının sonuçlarının değerlendirilmesi, komplikasyonların belirlenmesi ve yönetimi, KBH tedavisinin en önemli unsurlarını oluşturmaktadır. KBH olgularında böbrek fonksiyon kaybına paralel olarak; anemi, sistemik hipertansiyon, kardiyovasküler ve gastrointestinal bozukluklar, asit-baz dengesi ve elektrolit bozuklukları, hormonal değişiklikler, lipid metabolizması bozuklukları ve üremik ensefalopati gibi komplikasyonlar gelişmektedir. KBH'li hastaların böbrek fonksiyonlarının korunması ve yaşam kalitesinin iyileştirilmesinde bu komplikasyonların bilinmesi, destekleyici ve semptomatik tedavi uygulamalarıyla iyi yönetilebilmesi önemlidir. Bu anlamda KBH yönetimi, bir komplikasyon yönetimi olarak değerlendirilmelidir. Bu derlemede, KBH olgularında gelişen anemi, sistemik hipertansiyon, kardiyovasküler ve gastrointestinal bozukluklar, asit-baz dengesi, elektrolitler ve hormonlarla ilgili değişiklikler, lipid metabolizması bozuklukları ve nörolojik komplikasyonlar özetlenmiştir.

  • The clinical efficacy of pentoxifylline and l-glutamine on ischemia and reperfusion injury in cattle with displaced abomasum: a longitudinal study

    by M. Maden, R. Yildiz, R. Çöl, M. Arican, M. Ider, K. Parlak, B. Tras

    This study aimed to assess the clinical efficacy of pentoxifylline (PTX) and L-glutamine (L-Gln) treatment on ischemia and reperfusion (I/R) injury in the abomasal tissue, acute phase response (APR), oxidative stress (OS), cytokine response, hemostatic, and coagulation disorders in the 96-h period before and after surgery in displaced abomasum (DA) cases. The study sample consisted of 48 dairy cows with DA that were categorized into four groups as group S (Sham group) (9 Left displaced abomasum (LDA)+3 Right displaced abomasum (RDA), group P (PTX) (10 LDA+2 RDA), group G (L-Gln) (10 LDA+2 RDA), and group P+G (PTX+L-Gln) (10 LDA+2 RDA). Acute-phase protein (Haptoglobin), oxidative stress indicators (malondialdehyde, nitric oxide, and glutathione), cytokines (tumor necrosis factor (TNF)-alpha and interleukin-1 beta (IL-1 beta), coagulation factors (D-Dimer, Antithrombin (ATIII), Thrombin-antithrombin complex, Plasminogen activator inhibitor-1), and enzyme activities (lactate dehydrogenase, gamma-glutamyltransferase, sorbitol dehydrogenase, glutamate dehydrogenase, adenosine deaminase, myeloperoxidase, and creatine phosphokinase) in blood serum samples and coagulometric analyses of blood plasma were performed in samples taken before the operation and at 30 and 60 min and 2, 5, 10, 24, 48, 72, and 96 h after the operation. In DA cases, while post-operative treatment procedures with PTX and L-Gln were effective in decreasing APR and OS, these were ineffective in prohibiting the inflammatory response coordinated by cytokines. For the treatment and prevention of I/R injury in the DA cases, PTX and L-Gln procedures hold promise with their effects on APR, OS, and hemostatic dysfunction. Additional treatment procedures are required for the suppression of inflammatory response, and the effectiveness of preconditioning treatment may be evaluated.


  • EFFECTS OF GS-441524 ON CLINICAL AND HEMATOCHEMICAL PARAMETERS OF CATS WITH EFFUSIVE FIP OVER60 DAYS FOLLOW-UP

    by Erdem Gülersoy, Mehmet Maden

    Feline infectious peritonitis (FIP) is an important disease characterized by granulomatous changes in various organs including the ocular and central nervous system. FIP infection is referred as the best candidate for antiviral drug development studies due to the ineffectiveness of vaccines and being a cause of high mortality. The most important antiviral drugs developed against RNA viruses are nucleoside analogues such as GS-441524. In this study, GS-441524 was used in the treatment of three naturally infected cats with ocular lesions diagnosed with effusive FIP. The treatment of cats was planned as GS-441524 (5 mg / kg, SC, daily) administration for 12 weeks along with fluid therapy on the admission day. The treatment process included follow-ups with clinical and laboratory examinations on the admission 5th, 15th, 30th, 60th, 90th and 120th days. On the 5th day, clinical signs including ocular abnormalities and on the 30th day, laboratory findings were significantly improved in all 3 cats. While the cats were expected for monthly follow-ups, it was learned that the cats died on the 58th, 60th and 62nd days. It was concluded that GS-441524 (5 mg/kg/day, SC) has been proven to be beneficial for improving clinical, laboratory findings and animal welfare. However, it was evaluated that clinical studies involving more cases are required in order to determine the clinical efficacy of nucleoside analogues and investigate the causes of deaths occurred on the 58th, 60th and 62nd days of the treatment period with no symptoms that would grab the attention of the owners.

  • Open Access

    Comparison of overground and resting endoscopy in the diagnosis of the simple and complex dynamic upper respiratory tract abnormalities in racehorses

    by Cihan Kumas, Mehmet Maden, Orhan Pinar

    The purpose of the study was to find the source of complaints and to diagnose dynamic upper respiratory tract problems, which were derived from the horse owners, trainers, and jockeys, and to evaluate the overground endoscopic examination efficiency to determine the subclinical upper respiratory tract (URT) abnormalities, which were unable to diagnose with resting endoscopy. In the study, overground endoscopy has been used which nowadays there is a more useful and safe technique of performing endoscopy during ridden exercise in the natural field to diagnose dynamic upper respiratory tract (URT) abnormalities in comparison with the more traditional method of resting endoscopy. This study focused on 25 racehorses (Thoroughbred, n:22 and Arabian n: 3), which were admitted to Racehorse Hospital with complaints of fade abruptly and/or abnormal respiratory noise during the last meters of the race. All horses were examined for the complaints to be associated with systemic disorders and/or lameness, the racehorses with lameness and/or systemic disorders findings were excluded. Resting (post-exercise) and overground endoscopy by using Dr. Fritz® ETL-Equine Overground Endoscopy was performed on a polytrack racecourse in all racehorses. Observed abnormalities were recorded as simple and complex cases and the results of resting and dynamic examination were compared. It was concluded the overground endoscopic examination has a useful diagnostic value in determining the cause of abnormal respiratory noise and/or fade abruptly.